UNSPSC 51152040: Stercuronium

This classification denotes a muscle relaxant with the molecular formula C26H43N2.I, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K1477R7DDR, chemically known as (cona-4,6-dienin-3beta-yl)dimethylethylammonium iodide but generally known as stercuronium iodide, which bears US NIH Compound Identifier 71924. European Medicines Agency schedules Stercuronium iodide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10646MIG. The term STERCURONIUM IODIDE is an International Non-Proprietary Name.

As of Q4 2014, STERCURONIUM remains the US FDA Preferred Term for this commodity. SMILES: I.N1(CC23C(C4C(CC3)C3(C(=CC([N](CC)(C)C)CC3)C=C4)C)CCC2C1C)C.

UNSPSC 51152040 Stercuronium, a Commodity code, does not align with the state and local procurement activity currently tagged under it. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS for naloxone and safe drug deactivation systems—falls outside the nominal scope of the code. Stercuronium, as a chemical substance, bears no documented relationship to naloxone (an opioid antagonist) or drug deactivation equipment. The code shows no recent solicitations for the product its name suggests, and the one tagged opportunity represents a mismatch between the UNSPSC classification and the work actually being procured.

Seminole County posted this competitive bid on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through an IFB due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement supports community health initiatives and requires vendors to cover all shipping and delivery costs. The contract carries an initial two-year term with a one-year renewal option, involves a three-month probationary period, and is potentially funded through FEMA, introducing compliance requirements under the Clean Air Act and Federal Water Pollution Control Act. Vendors must meet E-Verify and drug-free workplace certification requirements and maintain workers' compensation, commercial general liability, and professional liability insurance. Until the classification is corrected or additional opportunities surface under this code, state and local activity here is not reliably trackable.